Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FiAsp vs. Aspart during postprandial exercise in T1D
NCT03659799Phase 4Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Apr 2019
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Montreal Clinical Research Institute. Started Apr 2019; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03659799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659799.